Global Home-Care Monitoring and Diagnostics Market By Offering (Devices – Wearable heart monitors, Home Respiratory Therapy Equipment and Insulin Delivery Devices, Home IV Pumps and Mobility solutions, Apnea & Sleep Monitors, Anticoagulation testing device and Electrocardiography (ECG) devices, Medication monitoring and Pulse Oximeter, Blood pressure monitor and Glucose monitors, Skin patches, shoes and belts, Maternity care trackers, Others, Solutions – Central Patient monitoring systems, Mobile patient monitoring solutions, Others, IT Infrastructure, Services, Others); By Application (Elderly, Disabled, Chronically ill patients, Others); By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
Home-care health monitoring happens to be the use of information technology and telecommunications in order to keep a track and monitor the health of patients who are not hospitalized and are in their homes. Patients living at their home are provided medical devices that monitor and measure important signs, like blood pressure, level of glucose, pulse, levels of oxygen in the blood along with the weight, and then this data is transmitted to the clinicians. Along with these devices, there are certain devices that are used for messaging or gathering information from those suffering regarding their symptoms, cognitive state and behaviour. Home care monitoring and diagnostics devices are usually inclusive of several healthcare products like the heart rate monitors, blood glucose level indicators, along with nebulizers that help in delivering efficient monitoring of the health and diagnosis and that provides physical support to individuals. All these home care monitoring devices are not just portable, but also can be used easily, and help in cutting down massive costs associated with the visit of the hospitals. The surge in the use of home health monitoring and diagnosis devices is being witnessed due to rising number of people suffering from chronic diseases and unhealthy lifestyle specifically in the population that lives in the urban areas. The global home-care monitoring and diagnostics market is anticipated to witness 12% CAGR over the forecast period. The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Home-Care Monitoring and Diagnostics Market Revenue & Forecast, (US$ Million), 2015 – 2030
Offering Outlook
Based on the offering outlook, the global home-care monitoring and diagnostics market has been segmented into devices, solutions, IT infrastructure, services, and others. While the devices segment is further bifurcated into wearable heart monitors, home respiratory therapy equipment and insulin delivery devices, home IV Pumps and mobility solutions, apnea & sleep monitors, anticoagulation testing device and electrocardiography (ECG) devices, medication monitoring and pulse oximeter, blood pressure monitor and glucose monitors, skin patches, shoes and belts, maternity care trackers, and others, the solutions segment is categorised into central patient monitoring systems, mobile patient monitoring solutions, and others. Wearable heart monitors has seen a huge spike in the demand, especially in the youngsters, while the blood pressure monitors and glucose monitors are being extensively used by middle-age and elderly people. It helps them reduce number of the visits to the hospitals. This is the reason why the devices segment accounts for majority of revenue generated by this market.
Region Outlook
On the basis of the region, North America made majority of the money for the global home-care monitoring and diagnostics market in the year 2021. Unhealthy lifestyle and consumption of junk food is the reason why the number of people, especially youngsters in the countries like the United States and Canada is why the home-care monitoring and diagnostics devices are being purchased rampantly. Along with rapid technological advancement in the region and higher awareness among people also aids the market grow.
Competitive Landscape
The report provides both, qualitative and quantitative research of global home-care monitoring and diagnostics market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the global home-care monitoring and diagnostics market are:
- Abbott Diagnostics
- Althea Group
- Bioptik Technology
- Chongqing Haray International Business
- Comarch SA.
- General Electric Company
- Johnson & Johnson
- Koninklijke Philips N.V.
- Medtronic
- Omron Healthcare
- Roche Diagnostics
- Other Market Participants
Global Home-Care Monitoring and Diagnostics Market:
By Offering
- Devices
- Wearable heart monitors
- Home Respiratory Therapy Equipment and Insulin Delivery Devices
- Home IV Pumps and Mobility solutions
- Apnea & Sleep Monitors
- Anticoagulation testing device and Electrocardiography (ECG) devices
- Medication monitoring and Pulse Oximeter
- Blood pressure monitor and Glucose monitors
- Skin patches, shoes and belts
- Maternity care trackers
- Others
- Solutions
- Central patient monitoring systems
- Mobile patent monitoring solutions
- Others
- IT Infrastructure
- Services
- Others
By Application
- Elderly
- Disabled
- Chronically ill patients
- Others
By Region
- North America
- U.S
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2020
1.2.2. Base
Year: 2021
1.2.3. Forecast
Years: 2022 - 2030
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Home-Care Monitoring and Diagnostics
Market
6. Market Synopsis:
Home-Care Monitoring and Diagnostics Market
7. Home-Care Monitoring and Diagnostics Market Analysis:
Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in
Home-Care Monitoring and Diagnostics Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Home-Care Monitoring and Diagnostics Market
7.6. Industry
Gross Margin Overview
7.7. Impact of
Covid-19 on Home-Care Monitoring and Diagnostics Market
8. Global Home-Care Monitoring and Diagnostics Market Analysis
and Forecasts, 2022 - 2030
8.1. Overview
8.1.1. Global Home-Care
Monitoring and Diagnostics Market Revenue (US$ Mn)
8.2. Global
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Offering
8.2.1. Devices
(Definition, Market Estimation and Penetration, 2015 - 2021, Market Estimation
(2015 - 2021), Market Forecast (2022 - 2030), Compound Annual Growth Rate
(CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East
and Africa, Latin America) and Information on Wearable heart monitors, Home
Respiratory Therapy Equipment and Insulin Delivery Devices, Home IV Pumps and
Mobility solutions, Apnea and Sleep Monitors, Anticoagulation testing device
and Electrocardiography (ECG) devices, Medication monitoring and Pulse
Oximeter, Blood pressure monitor and Glucose monitors, Skin patches, shoes and
belts, Maternity care trackers, Others)
8.2.1.1. Wearable
heart monitors
8.2.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
8.2.1.3. Home
IV Pumps and Mobility solutions
8.2.1.4. Apnea
and Sleep Monitors
8.2.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
8.2.1.6. Medication
monitoring and Pulse Oximeter
8.2.1.7. Blood
pressure monitor and Glucose monitors
8.2.1.8. Skin
patches, shoes and belts
8.2.1.9. Maternity
care trackers
8.2.1.10. Others
8.2.2. Solutions
(Definition, Market Estimation and Penetration, 2015 - 2021, Market Estimation
(2015 - 2021), Market Forecast (2022 - 2030), Compound Annual Growth Rate
(CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East
and Africa, Latin America) and Information on Central patient monitoring
systems, Mobile patent monitoring solutions, Others)
8.2.2.1. Central
patient monitoring systems
8.2.2.2. Mobile
patent monitoring solutions
8.2.2.3. Others
8.2.3. IT
Infrastructure
8.2.3.1. Definition
8.2.3.2. Market
Estimation and Penetration, 2015 - 2021
8.2.3.3. Market
Forecast, 2022 - 2030
8.2.3.4. Compound
Annual Growth Rate (CAGR)
8.2.3.5. Regional
Bifurcation
8.2.3.5.1. North America
8.2.3.5.1.1. Market
Estimation, 2015 - 2021
8.2.3.5.1.2. Market
Forecast, 2022 - 2030
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 - 2021
8.2.3.5.2.2. Market
Forecast, 2022 - 2030
8.2.3.5.3. Asia Pacific
8.2.3.5.3.1. Market
Estimation, 2015 - 2021
8.2.3.5.3.2. Market
Forecast, 2022 - 2030
8.2.3.5.4. Middle East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 - 2021
8.2.3.5.4.2. Market
Forecast, 2022 - 2030
8.2.3.5.5. Latin America
8.2.3.5.5.1. Market
Estimation, 2015 - 2021
8.2.3.5.5.2. Market
Forecast, 2022 - 2030
8.2.4. Services
8.2.4.1. Definition
8.2.4.2. Market
Estimation and Penetration, 2015 - 2021
8.2.4.3. Market
Forecast, 2022 - 2030
8.2.4.4. Compound
Annual Growth Rate (CAGR)
8.2.4.5. Regional
Bifurcation
8.2.4.5.1. North America
8.2.4.5.1.1. Market
Estimation, 2015 - 2021
8.2.4.5.1.2. Market
Forecast, 2022 - 2030
8.2.4.5.2. Europe
8.2.4.5.2.1. Market
Estimation, 2015 - 2021
8.2.4.5.2.2. Market
Forecast, 2022 - 2030
8.2.4.5.3. Asia Pacific
8.2.4.5.3.1. Market
Estimation, 2015 - 2021
8.2.4.5.3.2. Market
Forecast, 2022 - 2030
8.2.4.5.4. Middle East and Africa
8.2.4.5.4.1. Market
Estimation, 2015 - 2021
8.2.4.5.4.2. Market
Forecast, 2022 - 2030
8.2.4.5.5. Latin America
8.2.4.5.5.1. Market
Estimation, 2015 - 2021
8.2.4.5.5.2. Market
Forecast, 2022 - 2030
8.2.5. Others
8.2.5.1. Definition
8.2.5.2. Market
Estimation and Penetration, 2015 - 2021
8.2.5.3. Market
Forecast, 2022 - 2030
8.2.5.4. Compound
Annual Growth Rate (CAGR)
8.2.5.5. Regional
Bifurcation
8.2.5.5.1. North America
8.2.5.5.1.1. Market
Estimation, 2015 - 2021
8.2.5.5.1.2. Market
Forecast, 2022 - 2030
8.2.5.5.2. Europe
8.2.5.5.2.1. Market
Estimation, 2015 - 2021
8.2.5.5.2.2. Market
Forecast, 2022 - 2030
8.2.5.5.3. Asia Pacific
8.2.5.5.3.1. Market
Estimation, 2015 - 2021
8.2.5.5.3.2. Market
Forecast, 2022 - 2030
8.2.5.5.4. Middle East and Africa
8.2.5.5.4.1. Market
Estimation, 2015 - 2021
8.2.5.5.4.2. Market
Forecast, 2022 - 2030
8.2.5.5.5. Latin America
8.2.5.5.5.1. Market
Estimation, 2015 - 2021
8.2.5.5.5.2. Market
Forecast, 2022 - 2030
8.3. Key
Segment for Channeling Investments
8.3.1. By
Offering
9. Global Home-Care Monitoring and Diagnostics Market Analysis
and Forecasts, 2022 - 2030
9.1. Overview
9.2. Global
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Application
9.2.1. Elderly
9.2.1.1. Definition
9.2.1.2. Market
Estimation and Penetration, 2015 - 2021
9.2.1.3. Market
Forecast, 2022 - 2030
9.2.1.4. Compound
Annual Growth Rate (CAGR)
9.2.1.5. Regional
Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market
Estimation, 2015 - 2021
9.2.1.5.1.2. Market
Forecast, 2022 - 2030
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 - 2021
9.2.1.5.2.2. Market
Forecast, 2022 - 2030
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market
Estimation, 2015 - 2021
9.2.1.5.3.2. Market
Forecast, 2022 - 2030
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 - 2021
9.2.1.5.4.2. Market
Forecast, 2022 - 2030
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market
Estimation, 2015 - 2021
9.2.1.5.5.2. Market
Forecast, 2022 - 2030
9.2.2. Disabled
9.2.2.1. Definition
9.2.2.2. Market
Estimation and Penetration, 2015 - 2021
9.2.2.3. Market
Forecast, 2022 - 2030
9.2.2.4. Compound
Annual Growth Rate (CAGR)
9.2.2.5. Regional
Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market
Estimation, 2015 - 2021
9.2.2.5.1.2. Market
Forecast, 2022 - 2030
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 - 2021
9.2.2.5.2.2. Market
Forecast, 2022 - 2030
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market
Estimation, 2015 - 2021
9.2.2.5.3.2. Market
Forecast, 2022 - 2030
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 - 2021
9.2.2.5.4.2. Market
Forecast, 2022 - 2030
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market
Estimation, 2015 - 2021
9.2.2.5.5.2. Market
Forecast, 2022 - 2030
9.2.3. Chronically
ill patients
9.2.3.1. Definition
9.2.3.2. Market
Estimation and Penetration, 2015 - 2021
9.2.3.3. Market
Forecast, 2022 - 2030
9.2.3.4. Compound
Annual Growth Rate (CAGR)
9.2.3.5. Regional
Bifurcation
9.2.3.5.1. North America
9.2.3.5.1.1. Market
Estimation, 2015 - 2021
9.2.3.5.1.2. Market
Forecast, 2022 - 2030
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 - 2021
9.2.3.5.2.2. Market
Forecast, 2022 - 2030
9.2.3.5.3. Asia Pacific
9.2.3.5.3.1. Market
Estimation, 2015 - 2021
9.2.3.5.3.2. Market
Forecast, 2022 - 2030
9.2.3.5.4. Middle East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 - 2021
9.2.3.5.4.2. Market
Forecast, 2022 - 2030
9.2.3.5.5. Latin America
9.2.3.5.5.1. Market
Estimation, 2015 - 2021
9.2.3.5.5.2. Market
Forecast, 2022 - 2030
9.2.4. Others
9.2.4.1. Definition
9.2.4.2. Market
Estimation and Penetration, 2015 - 2021
9.2.4.3. Market
Forecast, 2022 - 2030
9.2.4.4. Compound
Annual Growth Rate (CAGR)
9.2.4.5. Regional
Bifurcation
9.2.4.5.1. North America
9.2.4.5.1.1. Market
Estimation, 2015 - 2021
9.2.4.5.1.2. Market
Forecast, 2022 - 2030
9.2.4.5.2. Europe
9.2.4.5.2.1. Market
Estimation, 2015 - 2021
9.2.4.5.2.2. Market
Forecast, 2022 - 2030
9.2.4.5.3. Asia Pacific
9.2.4.5.3.1. Market
Estimation, 2015 - 2021
9.2.4.5.3.2. Market
Forecast, 2022 - 2030
9.2.4.5.4. Middle East and Africa
9.2.4.5.4.1. Market
Estimation, 2015 - 2021
9.2.4.5.4.2. Market
Forecast, 2022 - 2030
9.2.4.5.5. Latin America
9.2.4.5.5.1. Market
Estimation, 2015 - 2021
9.2.4.5.5.2. Market
Forecast, 2022 - 2030
9.3. Key
Segment for Channeling Investments
9.3.1. By
Application
10. North America Home-Care Monitoring and Diagnostics Market
Analysis and Forecasts, 2022 - 2030
10.1. Overview
10.1.1. North
America Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn)
10.2. North
America Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Offering
10.2.1. Devices
10.2.1.1. Wearable
heart monitors
10.2.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
10.2.1.3. Home
IV Pumps and Mobility solutions
10.2.1.4. Apnea
and Sleep Monitors
10.2.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
10.2.1.6. Medication
monitoring and Pulse Oximeter
10.2.1.7. Blood
pressure monitor and Glucose monitors
10.2.1.8. Skin
patches, shoes and belts
10.2.1.9. Maternity
care trackers
10.2.1.10. Others
10.2.2. Solutions
10.2.2.1. Central
patient monitoring systems
10.2.2.2. Mobile
patent monitoring solutions
10.2.2.3. Others
10.2.3. IT
Infrastructure
10.2.4. Services
10.2.5. Others
10.3. North
America Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Application
10.3.1. Elderly
10.3.2. Disabled
10.3.3. Chronically
ill patients
10.3.4. Others
10.4. North
America Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Country
10.4.1. U.S
10.4.1.1. U.S
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Offering
10.4.1.1.1. Devices
10.4.1.1.1.1. Wearable
heart monitors
10.4.1.1.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
10.4.1.1.1.3. Home
IV Pumps and Mobility solutions
10.4.1.1.1.4. Apnea
and Sleep Monitors
10.4.1.1.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
10.4.1.1.1.6. Medication
monitoring and Pulse Oximeter
10.4.1.1.1.7. Blood
pressure monitor and Glucose monitors
10.4.1.1.1.8. Skin
patches, shoes and belts
10.4.1.1.1.9. Maternity
care trackers
10.4.1.1.1.10. Others
10.4.1.1.2. Solutions
10.4.1.1.2.1. Central
patient monitoring systems
10.4.1.1.2.2. Mobile
patent monitoring solutions
10.4.1.1.2.3. Others
10.4.1.1.3. IT Infrastructure
10.4.1.1.4. Services
10.4.1.1.5. Others
10.4.1.2. U.S
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Application
10.4.1.2.1. Elderly
10.4.1.2.2. Disabled
10.4.1.2.3. Chronically ill patients
10.4.1.2.4. Others
10.4.2. Canada
10.4.2.1. Canada
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Offering
10.4.2.1.1. Devices
10.4.2.1.1.1. Wearable
heart monitors
10.4.2.1.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
10.4.2.1.1.3. Home
IV Pumps and Mobility solutions
10.4.2.1.1.4. Apnea
and Sleep Monitors
10.4.2.1.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
10.4.2.1.1.6. Medication
monitoring and Pulse Oximeter
10.4.2.1.1.7. Blood
pressure monitor and Glucose monitors
10.4.2.1.1.8. Skin
patches, shoes and belts
10.4.2.1.1.9. Maternity
care trackers
10.4.2.1.1.10. Others
10.4.2.1.2. Solutions
10.4.2.1.2.1. Central
patient monitoring systems
10.4.2.1.2.2. Mobile
patent monitoring solutions
10.4.2.1.2.3. Others
10.4.2.1.3. IT Infrastructure
10.4.2.1.4. Services
10.4.2.1.5. Others
10.4.2.2. Canada
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Application
10.4.2.2.1. Elderly
10.4.2.2.2. Disabled
10.4.2.2.3. Chronically ill patients
10.4.2.2.4. Others
10.4.3. Mexico
10.4.3.1. Mexico
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Offering
10.4.3.1.1. Devices
10.4.3.1.1.1. Wearable
heart monitors
10.4.3.1.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
10.4.3.1.1.3. Home
IV Pumps and Mobility solutions
10.4.3.1.1.4. Apnea
and Sleep Monitors
10.4.3.1.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
10.4.3.1.1.6. Medication
monitoring and Pulse Oximeter
10.4.3.1.1.7. Blood
pressure monitor and Glucose monitors
10.4.3.1.1.8. Skin
patches, shoes and belts
10.4.3.1.1.9. Maternity
care trackers
10.4.3.1.1.10. Others
10.4.3.1.2. Solutions
10.4.3.1.2.1. Central
patient monitoring systems
10.4.3.1.2.2. Mobile
patent monitoring solutions
10.4.3.1.2.3. Others
10.4.3.1.3. IT Infrastructure
10.4.3.1.4. Services
10.4.3.1.5. Others
10.4.3.2. Mexico
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Application
10.4.3.2.1. Elderly
10.4.3.2.2. Disabled
10.4.3.2.3. Chronically ill patients
10.4.3.2.4. Others
10.4.4. Rest of
North America
10.4.4.1. Rest
of North America Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn)
and Forecasts, By Offering
10.4.4.1.1. Devices
10.4.4.1.1.1. Wearable
heart monitors
10.4.4.1.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
10.4.4.1.1.3. Home
IV Pumps and Mobility solutions
10.4.4.1.1.4. Apnea
and Sleep Monitors
10.4.4.1.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
10.4.4.1.1.6. Medication
monitoring and Pulse Oximeter
10.4.4.1.1.7. Blood
pressure monitor and Glucose monitors
10.4.4.1.1.8. Skin
patches, shoes and belts
10.4.4.1.1.9. Maternity
care trackers
10.4.4.1.1.10. Others
10.4.4.1.2. Solutions
10.4.4.1.2.1. Central
patient monitoring systems
10.4.4.1.2.2. Mobile
patent monitoring solutions
10.4.4.1.2.3. Others
10.4.4.1.3. IT Infrastructure
10.4.4.1.4. Services
10.4.4.1.5. Others
10.4.4.2. Rest
of North America Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn)
and Forecasts, By Application
10.4.4.2.1. Elderly
10.4.4.2.2. Disabled
10.4.4.2.3. Chronically ill patients
10.4.4.2.4. Others
10.5. Key
Segment for Channeling Investments
10.5.1. By
Country
10.5.2. By
Offering
10.5.3. By
Application
11. Europe Home-Care Monitoring and Diagnostics Market Analysis
and Forecasts, 2022 - 2030
11.1. Overview
11.1.1. Europe
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn)
11.2. Europe
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Offering
11.2.1. Devices
11.2.1.1. Wearable
heart monitors
11.2.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
11.2.1.3. Home
IV Pumps and Mobility solutions
11.2.1.4. Apnea
and Sleep Monitors
11.2.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
11.2.1.6. Medication
monitoring and Pulse Oximeter
11.2.1.7. Blood
pressure monitor and Glucose monitors
11.2.1.8. Skin
patches, shoes and belts
11.2.1.9. Maternity
care trackers
11.2.1.10. Others
11.2.2. Solutions
11.2.2.1. Central
patient monitoring systems
11.2.2.2. Mobile
patent monitoring solutions
11.2.2.3. Others
11.2.3. IT
Infrastructure
11.2.4. Services
11.2.5. Others
11.3. Europe Home-Care
Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Application
11.3.1. Elderly
11.3.2. Disabled
11.3.3. Chronically
ill patients
11.3.4. Others
11.4. Europe
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Country
11.4.1. France
11.4.1.1. France
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Offering
11.4.1.1.1. Devices
11.4.1.1.1.1. Wearable
heart monitors
11.4.1.1.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
11.4.1.1.1.3. Home
IV Pumps and Mobility solutions
11.4.1.1.1.4. Apnea
and Sleep Monitors
11.4.1.1.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
11.4.1.1.1.6. Medication
monitoring and Pulse Oximeter
11.4.1.1.1.7. Blood
pressure monitor and Glucose monitors
11.4.1.1.1.8. Skin
patches, shoes and belts
11.4.1.1.1.9. Maternity
care trackers
11.4.1.1.1.10. Others
11.4.1.1.2. Solutions
11.4.1.1.2.1. Central
patient monitoring systems
11.4.1.1.2.2. Mobile
patent monitoring solutions
11.4.1.1.2.3. Others
11.4.1.1.3. IT Infrastructure
11.4.1.1.4. Services
11.4.1.1.5. Others
11.4.1.2. France
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Application
11.4.1.2.1. Elderly
11.4.1.2.2. Disabled
11.4.1.2.3. Chronically ill patients
11.4.1.2.4. Others
11.4.2. The UK
11.4.2.1. The
UK Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Offering
11.4.2.1.1. Devices
11.4.2.1.1.1. Wearable
heart monitors
11.4.2.1.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
11.4.2.1.1.3. Home
IV Pumps and Mobility solutions
11.4.2.1.1.4. Apnea
and Sleep Monitors
11.4.2.1.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
11.4.2.1.1.6. Medication
monitoring and Pulse Oximeter
11.4.2.1.1.7. Blood
pressure monitor and Glucose monitors
11.4.2.1.1.8. Skin
patches, shoes and belts
11.4.2.1.1.9. Maternity
care trackers
11.4.2.1.1.10. Others
11.4.2.1.2. Solutions
11.4.2.1.2.1. Central
patient monitoring systems
11.4.2.1.2.2. Mobile
patent monitoring solutions
11.4.2.1.2.3. Others
11.4.2.1.3. IT Infrastructure
11.4.2.1.4. Services
11.4.2.1.5. Others
11.4.2.2. The
UK Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Application
11.4.2.2.1. Elderly
11.4.2.2.2. Disabled
11.4.2.2.3. Chronically ill patients
11.4.2.2.4. Others
11.4.3. Spain
11.4.3.1. Spain
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Offering
11.4.3.1.1. Devices
11.4.3.1.1.1. Wearable
heart monitors
11.4.3.1.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
11.4.3.1.1.3. Home
IV Pumps and Mobility solutions
11.4.3.1.1.4. Apnea
and Sleep Monitors
11.4.3.1.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
11.4.3.1.1.6. Medication
monitoring and Pulse Oximeter
11.4.3.1.1.7. Blood
pressure monitor and Glucose monitors
11.4.3.1.1.8. Skin
patches, shoes and belts
11.4.3.1.1.9. Maternity
care trackers
11.4.3.1.1.10. Others
11.4.3.1.2. Solutions
11.4.3.1.2.1. Central
patient monitoring systems
11.4.3.1.2.2. Mobile
patent monitoring solutions
11.4.3.1.2.3. Others
11.4.3.1.3. IT Infrastructure
11.4.3.1.4. Services
11.4.3.1.5. Others
11.4.3.2. Spain
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Application
11.4.3.2.1. Elderly
11.4.3.2.2. Disabled
11.4.3.2.3. Chronically ill patients
11.4.3.2.4. Others
11.4.4. Germany
11.4.4.1. Germany
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Offering
11.4.4.1.1. Devices
11.4.4.1.1.1. Wearable
heart monitors
11.4.4.1.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
11.4.4.1.1.3. Home
IV Pumps and Mobility solutions
11.4.4.1.1.4. Apnea
and Sleep Monitors
11.4.4.1.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
11.4.4.1.1.6. Medication
monitoring and Pulse Oximeter
11.4.4.1.1.7. Blood
pressure monitor and Glucose monitors
11.4.4.1.1.8. Skin
patches, shoes and belts
11.4.4.1.1.9. Maternity
care trackers
11.4.4.1.1.10. Others
11.4.4.1.2. Solutions
11.4.4.1.2.1. Central
patient monitoring systems
11.4.4.1.2.2. Mobile
patent monitoring solutions
11.4.4.1.2.3. Others
11.4.4.1.3. IT Infrastructure
11.4.4.1.4. Services
11.4.4.1.5. Others
11.4.4.2. Germany
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Application
11.4.4.2.1. Elderly
11.4.4.2.2. Disabled
11.4.4.2.3. Chronically ill patients
11.4.4.2.4. Others
11.4.5. Italy
11.4.5.1. Italy
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Offering
11.4.5.1.1. Devices
11.4.5.1.1.1. Wearable
heart monitors
11.4.5.1.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
11.4.5.1.1.3. Home
IV Pumps and Mobility solutions
11.4.5.1.1.4. Apnea
and Sleep Monitors
11.4.5.1.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
11.4.5.1.1.6. Medication
monitoring and Pulse Oximeter
11.4.5.1.1.7. Blood
pressure monitor and Glucose monitors
11.4.5.1.1.8. Skin
patches, shoes and belts
11.4.5.1.1.9. Maternity
care trackers
11.4.5.1.1.10. Others
11.4.5.1.2. Solutions
11.4.5.1.2.1. Central
patient monitoring systems
11.4.5.1.2.2. Mobile
patent monitoring solutions
11.4.5.1.2.3. Others
11.4.5.1.3. IT Infrastructure
11.4.5.1.4. Services
11.4.5.1.5. Others
11.4.5.2. Italy
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Application
11.4.5.2.1. Elderly
11.4.5.2.2. Disabled
11.4.5.2.3. Chronically ill patients
11.4.5.2.4. Others
11.4.6. Nordic
Countries
11.4.6.1. Nordic
Countries Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Offering
11.4.6.1.1. Devices
11.4.6.1.1.1. Wearable
heart monitors
11.4.6.1.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
11.4.6.1.1.3. Home
IV Pumps and Mobility solutions
11.4.6.1.1.4. Apnea
and Sleep Monitors
11.4.6.1.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
11.4.6.1.1.6. Medication
monitoring and Pulse Oximeter
11.4.6.1.1.7. Blood
pressure monitor and Glucose monitors
11.4.6.1.1.8. Skin
patches, shoes and belts
11.4.6.1.1.9. Maternity
care trackers
11.4.6.1.1.10. Others
11.4.6.1.2. Solutions
11.4.6.1.2.1. Central
patient monitoring systems
11.4.6.1.2.2. Mobile
patent monitoring solutions
11.4.6.1.2.3. Others
11.4.6.1.3. IT Infrastructure
11.4.6.1.4. Services
11.4.6.1.5. Others
11.4.6.2. Nordic
Countries Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Application
11.4.6.2.1. Elderly
11.4.6.2.2. Disabled
11.4.6.2.3. Chronically ill patients
11.4.6.2.4. Others
11.4.6.3. Nordic
Countries Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Country
11.4.6.3.1. Denmark
11.4.6.3.2. Finland
11.4.6.3.3. Iceland
11.4.6.3.4. Sweden
11.4.6.3.5. Norway
11.4.7. Benelux
Union
11.4.7.1. Benelux
Union Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Offering
11.4.7.1.1. Devices
11.4.7.1.1.1. Wearable
heart monitors
11.4.7.1.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
11.4.7.1.1.3. Home
IV Pumps and Mobility solutions
11.4.7.1.1.4. Apnea
and Sleep Monitors
11.4.7.1.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
11.4.7.1.1.6. Medication
monitoring and Pulse Oximeter
11.4.7.1.1.7. Blood
pressure monitor and Glucose monitors
11.4.7.1.1.8. Skin
patches, shoes and belts
11.4.7.1.1.9. Maternity
care trackers
11.4.7.1.1.10. Others
11.4.7.1.2. Solutions
11.4.7.1.2.1. Central
patient monitoring systems
11.4.7.1.2.2. Mobile
patent monitoring solutions
11.4.7.1.2.3. Others
11.4.7.1.3. IT Infrastructure
11.4.7.1.4. Services
11.4.7.1.5. Others
11.4.7.2. Benelux
Union Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Application
11.4.7.2.1. Elderly
11.4.7.2.2. Disabled
11.4.7.2.3. Chronically ill patients
11.4.7.2.4. Others
11.4.7.3. Benelux
Union Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Country
11.4.7.3.1. Belgium
11.4.7.3.2. The Netherlands
11.4.7.3.3. Luxembourg
11.4.8. Rest of
Europe
11.4.8.1. Rest
of Europe Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Offering
11.4.8.1.1. Devices
11.4.8.1.1.1. Wearable
heart monitors
11.4.8.1.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
11.4.8.1.1.3. Home
IV Pumps and Mobility solutions
11.4.8.1.1.4. Apnea
and Sleep Monitors
11.4.8.1.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
11.4.8.1.1.6. Medication
monitoring and Pulse Oximeter
11.4.8.1.1.7. Blood
pressure monitor and Glucose monitors
11.4.8.1.1.8. Skin
patches, shoes and belts
11.4.8.1.1.9. Maternity
care trackers
11.4.8.1.1.10. Others
11.4.8.1.2. Solutions
11.4.8.1.2.1. Central
patient monitoring systems
11.4.8.1.2.2. Mobile
patent monitoring solutions
11.4.8.1.2.3. Others
11.4.8.1.3. IT Infrastructure
11.4.8.1.4. Services
11.4.8.1.5. Others
11.4.8.2. Rest
of Europe Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Application
11.4.8.2.1. Elderly
11.4.8.2.2. Disabled
11.4.8.2.3. Chronically ill patients
11.4.8.2.4. Others
11.5. Key
Segment for Channeling Investments
11.5.1. By
Country
11.5.2. By
Offering
11.5.3. By
Application
12. Asia Pacific Home-Care Monitoring and Diagnostics Market
Analysis and Forecasts, 2022 - 2030
12.1. Overview
12.1.1. Asia
Pacific Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn)
12.2. Asia
Pacific Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Offering
12.2.1. Devices
12.2.1.1. Wearable
heart monitors
12.2.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
12.2.1.3. Home
IV Pumps and Mobility solutions
12.2.1.4. Apnea
and Sleep Monitors
12.2.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
12.2.1.6. Medication
monitoring and Pulse Oximeter
12.2.1.7. Blood
pressure monitor and Glucose monitors
12.2.1.8. Skin
patches, shoes and belts
12.2.1.9. Maternity
care trackers
12.2.1.10. Others
12.2.2. Solutions
12.2.2.1. Central
patient monitoring systems
12.2.2.2. Mobile
patent monitoring solutions
12.2.2.3. Others
12.2.3. IT
Infrastructure
12.2.4. Services
12.2.5. Others
12.3. Asia
Pacific Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Application
12.3.1. Elderly
12.3.2. Disabled
12.3.3. Chronically
ill patients
12.3.4. Others
12.4. Asia
Pacific Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Country
12.4.1. China
12.4.1.1. China
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Offering
12.4.1.1.1. Devices
12.4.1.1.1.1. Wearable
heart monitors
12.4.1.1.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
12.4.1.1.1.3. Home
IV Pumps and Mobility solutions
12.4.1.1.1.4. Apnea
and Sleep Monitors
12.4.1.1.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
12.4.1.1.1.6. Medication
monitoring and Pulse Oximeter
12.4.1.1.1.7. Blood
pressure monitor and Glucose monitors
12.4.1.1.1.8. Skin
patches, shoes and belts
12.4.1.1.1.9. Maternity
care trackers
12.4.1.1.1.10. Others
12.4.1.1.2. Solutions
12.4.1.1.2.1. Central
patient monitoring systems
12.4.1.1.2.2. Mobile
patent monitoring solutions
12.4.1.1.2.3. Others
12.4.1.1.3. IT Infrastructure
12.4.1.1.4. Services
12.4.1.1.5. Others
12.4.1.2. China
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By Application
12.4.1.2.1. Elderly
12.4.1.2.2. Disabled
12.4.1.2.3. Chronically ill patients
12.4.1.2.4. Others
12.4.2. Japan
12.4.2.1. Japan
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Offering
12.4.2.1.1. Devices
12.4.2.1.1.1. Wearable
heart monitors
12.4.2.1.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
12.4.2.1.1.3. Home
IV Pumps and Mobility solutions
12.4.2.1.1.4. Apnea
and Sleep Monitors
12.4.2.1.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
12.4.2.1.1.6. Medication
monitoring and Pulse Oximeter
12.4.2.1.1.7. Blood
pressure monitor and Glucose monitors
12.4.2.1.1.8. Skin
patches, shoes and belts
12.4.2.1.1.9. Maternity
care trackers
12.4.2.1.1.10. Others
12.4.2.1.2. Solutions
12.4.2.1.2.1. Central
patient monitoring systems
12.4.2.1.2.2. Mobile
patent monitoring solutions
12.4.2.1.2.3. Others
12.4.2.1.3. IT Infrastructure
12.4.2.1.4. Services
12.4.2.1.5. Others
12.4.2.2. Japan
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Application
12.4.2.2.1. Elderly
12.4.2.2.2. Disabled
12.4.2.2.3. Chronically ill patients
12.4.2.2.4. Others
12.4.3. India
12.4.3.1. India
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Offering
12.4.3.1.1. Devices
12.4.3.1.1.1. Wearable
heart monitors
12.4.3.1.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
12.4.3.1.1.3. Home
IV Pumps and Mobility solutions
12.4.3.1.1.4. Apnea
and Sleep Monitors
12.4.3.1.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
12.4.3.1.1.6. Medication
monitoring and Pulse Oximeter
12.4.3.1.1.7. Blood
pressure monitor and Glucose monitors
12.4.3.1.1.8. Skin
patches, shoes and belts
12.4.3.1.1.9. Maternity
care trackers
12.4.3.1.1.10. Others
12.4.3.1.2. Solutions
12.4.3.1.2.1. Central
patient monitoring systems
12.4.3.1.2.2. Mobile
patent monitoring solutions
12.4.3.1.2.3. Others
12.4.3.1.3. IT Infrastructure
12.4.3.1.4. Services
12.4.3.1.5. Others
12.4.3.2. India
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Application
12.4.3.2.1. Elderly
12.4.3.2.2. Disabled
12.4.3.2.3. Chronically ill patients
12.4.3.2.4. Others
12.4.4. New
Zealand
12.4.4.1. New
Zealand Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Offering
12.4.4.1.1. Devices
12.4.4.1.1.1. Wearable
heart monitors
12.4.4.1.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
12.4.4.1.1.3. Home
IV Pumps and Mobility solutions
12.4.4.1.1.4. Apnea
and Sleep Monitors
12.4.4.1.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
12.4.4.1.1.6. Medication
monitoring and Pulse Oximeter
12.4.4.1.1.7. Blood
pressure monitor and Glucose monitors
12.4.4.1.1.8. Skin
patches, shoes and belts
12.4.4.1.1.9. Maternity
care trackers
12.4.4.1.1.10. Others
12.4.4.1.2. Solutions
12.4.4.1.2.1. Central
patient monitoring systems
12.4.4.1.2.2. Mobile
patent monitoring solutions
12.4.4.1.2.3. Others
12.4.4.1.3. IT Infrastructure
12.4.4.1.4. Services
12.4.4.1.5. Others
12.4.4.2. New
Zealand Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Application
12.4.4.2.1. Elderly
12.4.4.2.2. Disabled
12.4.4.2.3. Chronically ill patients
12.4.4.2.4. Others
12.4.5. Australia
12.4.5.1. Australia
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Offering
12.4.5.1.1. Devices
12.4.5.1.1.1. Wearable
heart monitors
12.4.5.1.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
12.4.5.1.1.3. Home
IV Pumps and Mobility solutions
12.4.5.1.1.4. Apnea
and Sleep Monitors
12.4.5.1.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
12.4.5.1.1.6. Medication
monitoring and Pulse Oximeter
12.4.5.1.1.7. Blood
pressure monitor and Glucose monitors
12.4.5.1.1.8. Skin
patches, shoes and belts
12.4.5.1.1.9. Maternity
care trackers
12.4.5.1.1.10. Others
12.4.5.1.2. Solutions
12.4.5.1.2.1. Central
patient monitoring systems
12.4.5.1.2.2. Mobile
patent monitoring solutions
12.4.5.1.2.3. Others
12.4.5.1.3. IT Infrastructure
12.4.5.1.4. Services
12.4.5.1.5. Others
12.4.5.2. Australia
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Application
12.4.5.2.1. Elderly
12.4.5.2.2. Disabled
12.4.5.2.3. Chronically ill patients
12.4.5.2.4. Others
12.4.6. South
Korea
12.4.6.1. South
Korea Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Offering
12.4.6.1.1. Devices
12.4.6.1.1.1. Wearable
heart monitors
12.4.6.1.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
12.4.6.1.1.3. Home
IV Pumps and Mobility solutions
12.4.6.1.1.4. Apnea
and Sleep Monitors
12.4.6.1.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
12.4.6.1.1.6. Medication
monitoring and Pulse Oximeter
12.4.6.1.1.7. Blood
pressure monitor and Glucose monitors
12.4.6.1.1.8. Skin
patches, shoes and belts
12.4.6.1.1.9. Maternity
care trackers
12.4.6.1.1.10. Others
12.4.6.1.2. Solutions
12.4.6.1.2.1. Central
patient monitoring systems
12.4.6.1.2.2. Mobile
patent monitoring solutions
12.4.6.1.2.3. Others
12.4.6.1.3. IT Infrastructure
12.4.6.1.4. Services
12.4.6.1.5. Others
12.4.6.2. South
Korea Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Application
12.4.6.2.1. Elderly
12.4.6.2.2. Disabled
12.4.6.2.3. Chronically ill patients
12.4.6.2.4. Others
12.4.7. Southeast
Asia
12.4.7.1. Southeast
Asia Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Offering
12.4.7.1.1. Devices
12.4.7.1.1.1. Wearable
heart monitors
12.4.7.1.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
12.4.7.1.1.3. Home
IV Pumps and Mobility solutions
12.4.7.1.1.4. Apnea
and Sleep Monitors
12.4.7.1.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
12.4.7.1.1.6. Medication
monitoring and Pulse Oximeter
12.4.7.1.1.7. Blood
pressure monitor and Glucose monitors
12.4.7.1.1.8. Skin
patches, shoes and belts
12.4.7.1.1.9. Maternity
care trackers
12.4.7.1.1.10. Others
12.4.7.1.2. Solutions
12.4.7.1.2.1. Central
patient monitoring systems
12.4.7.1.2.2. Mobile
patent monitoring solutions
12.4.7.1.2.3. Others
12.4.7.1.3. IT Infrastructure
12.4.7.1.4. Services
12.4.7.1.5. Others
12.4.7.2. Southeast
Asia Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Application
12.4.7.2.1. Elderly
12.4.7.2.2. Disabled
12.4.7.2.3. Chronically ill patients
12.4.7.2.4. Others
12.4.7.3. Southeast
Asia Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Country
12.4.7.3.1. Indonesia
12.4.7.3.2. Thailand
12.4.7.3.3. Malaysia
12.4.7.3.4. Singapore
12.4.7.3.5. Rest of Southeast Asia
12.4.8. Rest of
Asia Pacific
12.4.8.1. Rest
of Asia Pacific Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn)
and Forecasts, By Offering
12.4.8.1.1. Devices
12.4.8.1.1.1. Wearable
heart monitors
12.4.8.1.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
12.4.8.1.1.3. Home
IV Pumps and Mobility solutions
12.4.8.1.1.4. Apnea
and Sleep Monitors
12.4.8.1.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
12.4.8.1.1.6. Medication
monitoring and Pulse Oximeter
12.4.8.1.1.7. Blood
pressure monitor and Glucose monitors
12.4.8.1.1.8. Skin
patches, shoes and belts
12.4.8.1.1.9. Maternity
care trackers
12.4.8.1.1.10. Others
12.4.8.1.2. Solutions
12.4.8.1.2.1. Central
patient monitoring systems
12.4.8.1.2.2. Mobile
patent monitoring solutions
12.4.8.1.2.3. Others
12.4.8.1.3. IT Infrastructure
12.4.8.1.4. Services
12.4.8.1.5. Others
12.4.8.2. Rest
of Asia Pacific Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn)
and Forecasts, By Application
12.4.8.2.1. Elderly
12.4.8.2.2. Disabled
12.4.8.2.3. Chronically ill patients
12.4.8.2.4. Others
12.5. Key
Segment for Channeling Investments
12.5.1. By
Country
12.5.2. By
Offering
12.5.3. By
Application
13. Middle East and Africa Home-Care Monitoring and Diagnostics
Market Analysis and Forecasts, 2022 - 2030
13.1. Overview
13.1.1. Middle
East and Africa Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn)
13.2. Middle
East and Africa Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn)
and Forecasts, By Offering
13.2.1. Devices
13.2.1.1. Wearable
heart monitors
13.2.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
13.2.1.3. Home
IV Pumps and Mobility solutions
13.2.1.4. Apnea
and Sleep Monitors
13.2.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
13.2.1.6. Medication
monitoring and Pulse Oximeter
13.2.1.7. Blood
pressure monitor and Glucose monitors
13.2.1.8. Skin
patches, shoes and belts
13.2.1.9. Maternity
care trackers
13.2.1.10. Others
13.2.2. Solutions
13.2.2.1. Central
patient monitoring systems
13.2.2.2. Mobile
patent monitoring solutions
13.2.2.3. Others
13.2.3. IT
Infrastructure
13.2.4. Services
13.2.5. Others
13.3. Middle
East and Africa Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn)
and Forecasts, By Application
13.3.1. Elderly
13.3.2. Disabled
13.3.3. Chronically
ill patients
13.3.4. Others
13.4. Middle
East and Africa Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn)
and Forecasts, By Country
13.4.1. Saudi
Arabia
13.4.1.1. Saudi
Arabia Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Offering
13.4.1.1.1. Devices
13.4.1.1.1.1. Wearable
heart monitors
13.4.1.1.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
13.4.1.1.1.3. Home
IV Pumps and Mobility solutions
13.4.1.1.1.4. Apnea
and Sleep Monitors
13.4.1.1.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
13.4.1.1.1.6. Medication
monitoring and Pulse Oximeter
13.4.1.1.1.7. Blood
pressure monitor and Glucose monitors
13.4.1.1.1.8. Skin
patches, shoes and belts
13.4.1.1.1.9. Maternity
care trackers
13.4.1.1.1.10. Others
13.4.1.1.2. Solutions
13.4.1.1.2.1. Central
patient monitoring systems
13.4.1.1.2.2. Mobile
patent monitoring solutions
13.4.1.1.2.3. Others
13.4.1.1.3. IT Infrastructure
13.4.1.1.4. Services
13.4.1.1.5. Others
13.4.1.2. Saudi
Arabia Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Application
13.4.1.2.1. Elderly
13.4.1.2.2. Disabled
13.4.1.2.3. Chronically ill patients
13.4.1.2.4. Others
13.4.2. UAE
13.4.2.1. UAE
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Offering
13.4.2.1.1. Devices
13.4.2.1.1.1. Wearable
heart monitors
13.4.2.1.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
13.4.2.1.1.3. Home
IV Pumps and Mobility solutions
13.4.2.1.1.4. Apnea
and Sleep Monitors
13.4.2.1.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
13.4.2.1.1.6. Medication
monitoring and Pulse Oximeter
13.4.2.1.1.7. Blood
pressure monitor and Glucose monitors
13.4.2.1.1.8. Skin
patches, shoes and belts
13.4.2.1.1.9. Maternity
care trackers
13.4.2.1.1.10. Others
13.4.2.1.2. Solutions
13.4.2.1.2.1. Central
patient monitoring systems
13.4.2.1.2.2. Mobile
patent monitoring solutions
13.4.2.1.2.3. Others
13.4.2.1.3. IT Infrastructure
13.4.2.1.4. Services
13.4.2.1.5. Others
13.4.2.2. UAE
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Application
13.4.2.2.1. Elderly
13.4.2.2.2. Disabled
13.4.2.2.3. Chronically ill patients
13.4.2.2.4. Others
13.4.3. Egypt
13.4.3.1. Egypt
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Offering
13.4.3.1.1. Devices
13.4.3.1.1.1. Wearable
heart monitors
13.4.3.1.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
13.4.3.1.1.3. Home
IV Pumps and Mobility solutions
13.4.3.1.1.4. Apnea
and Sleep Monitors
13.4.3.1.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
13.4.3.1.1.6. Medication
monitoring and Pulse Oximeter
13.4.3.1.1.7. Blood
pressure monitor and Glucose monitors
13.4.3.1.1.8. Skin
patches, shoes and belts
13.4.3.1.1.9. Maternity
care trackers
13.4.3.1.1.10. Others
13.4.3.1.2. Solutions
13.4.3.1.2.1. Central
patient monitoring systems
13.4.3.1.2.2. Mobile
patent monitoring solutions
13.4.3.1.2.3. Others
13.4.3.1.3. IT Infrastructure
13.4.3.1.4. Services
13.4.3.1.5. Others
13.4.3.2. Egypt
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Application
13.4.3.2.1. Elderly
13.4.3.2.2. Disabled
13.4.3.2.3. Chronically ill patients
13.4.3.2.4. Others
13.4.4. Kuwait
13.4.4.1. Kuwait
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Offering
13.4.4.1.1. Devices
13.4.4.1.1.1. Wearable
heart monitors
13.4.4.1.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
13.4.4.1.1.3. Home
IV Pumps and Mobility solutions
13.4.4.1.1.4. Apnea
and Sleep Monitors
13.4.4.1.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
13.4.4.1.1.6. Medication
monitoring and Pulse Oximeter
13.4.4.1.1.7. Blood
pressure monitor and Glucose monitors
13.4.4.1.1.8. Skin
patches, shoes and belts
13.4.4.1.1.9. Maternity
care trackers
13.4.4.1.1.10. Others
13.4.4.1.2. Solutions
13.4.4.1.2.1. Central
patient monitoring systems
13.4.4.1.2.2. Mobile
patent monitoring solutions
13.4.4.1.2.3. Others
13.4.4.1.3. IT Infrastructure
13.4.4.1.4. Services
13.4.4.1.5. Others
13.4.4.2. Kuwait
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Application
13.4.4.2.1. Elderly
13.4.4.2.2. Disabled
13.4.4.2.3. Chronically ill patients
13.4.4.2.4. Others
13.4.5. South
Africa
13.4.5.1. South
Africa Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Offering
13.4.5.1.1. Devices
13.4.5.1.1.1. Wearable
heart monitors
13.4.5.1.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
13.4.5.1.1.3. Home
IV Pumps and Mobility solutions
13.4.5.1.1.4. Apnea
and Sleep Monitors
13.4.5.1.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
13.4.5.1.1.6. Medication
monitoring and Pulse Oximeter
13.4.5.1.1.7. Blood
pressure monitor and Glucose monitors
13.4.5.1.1.8. Skin
patches, shoes and belts
13.4.5.1.1.9. Maternity
care trackers
13.4.5.1.1.10. Others
13.4.5.1.2. Solutions
13.4.5.1.2.1. Central
patient monitoring systems
13.4.5.1.2.2. Mobile
patent monitoring solutions
13.4.5.1.2.3. Others
13.4.5.1.3. IT Infrastructure
13.4.5.1.4. Services
13.4.5.1.5. Others
13.4.5.2. South
Africa Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Application
13.4.5.2.1. Elderly
13.4.5.2.2. Disabled
13.4.5.2.3. Chronically ill patients
13.4.5.2.4. Others
13.4.6. Rest of
Middle East & Africa
13.4.6.1. Rest
of Middle East & Africa Home-Care Monitoring and Diagnostics Market Revenue
(US$ Mn) and Forecasts, By Offering
13.4.6.1.1. Devices
13.4.6.1.1.1. Wearable
heart monitors
13.4.6.1.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
13.4.6.1.1.3. Home
IV Pumps and Mobility solutions
13.4.6.1.1.4. Apnea
and Sleep Monitors
13.4.6.1.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
13.4.6.1.1.6. Medication
monitoring and Pulse Oximeter
13.4.6.1.1.7. Blood
pressure monitor and Glucose monitors
13.4.6.1.1.8. Skin
patches, shoes and belts
13.4.6.1.1.9. Maternity
care trackers
13.4.6.1.1.10. Others
13.4.6.1.2. Solutions
13.4.6.1.2.1. Central
patient monitoring systems
13.4.6.1.2.2. Mobile
patent monitoring solutions
13.4.6.1.2.3. Others
13.4.6.1.3. IT Infrastructure
13.4.6.1.4. Services
13.4.6.1.5. Others
13.4.6.2. Rest
of Middle East & Africa Home-Care Monitoring and Diagnostics Market Revenue
(US$ Mn) and Forecasts, By Application
13.4.6.2.1. Elderly
13.4.6.2.2. Disabled
13.4.6.2.3. Chronically ill patients
13.4.6.2.4. Others
13.5. Key
Segment for Channeling Investments
13.5.1. By
Country
13.5.2. By
Offering
13.5.3. By
Application
14. Latin America Home-Care Monitoring and Diagnostics Market
Analysis and Forecasts, 2022 - 2030
14.1. Overview
14.1.1. Latin
America Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn)
14.2. Latin
America Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Offering
14.2.1. Devices
14.2.1.1. Wearable
heart monitors
14.2.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
14.2.1.3. Home
IV Pumps and Mobility solutions
14.2.1.4. Apnea
and Sleep Monitors
14.2.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
14.2.1.6. Medication
monitoring and Pulse Oximeter
14.2.1.7. Blood
pressure monitor and Glucose monitors
14.2.1.8. Skin
patches, shoes and belts
14.2.1.9. Maternity
care trackers
14.2.1.10. Others
14.2.2. Solutions
14.2.2.1. Central
patient monitoring systems
14.2.2.2. Mobile
patent monitoring solutions
14.2.2.3. Others
14.2.3. IT
Infrastructure
14.2.4. Services
14.2.5. Others
14.3. Latin
America Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Application
14.3.1. Elderly
14.3.2. Disabled
14.3.3. Chronically
ill patients
14.3.4. Others
14.4. Latin
America Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Country
14.4.1. Brazil
14.4.1.1. Brazil
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Offering
14.4.1.1.1. Devices
14.4.1.1.1.1. Wearable
heart monitors
14.4.1.1.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
14.4.1.1.1.3. Home
IV Pumps and Mobility solutions
14.4.1.1.1.4. Apnea
and Sleep Monitors
14.4.1.1.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
14.4.1.1.1.6. Medication
monitoring and Pulse Oximeter
14.4.1.1.1.7. Blood
pressure monitor and Glucose monitors
14.4.1.1.1.8. Skin
patches, shoes and belts
14.4.1.1.1.9. Maternity
care trackers
14.4.1.1.1.10. Others
14.4.1.1.2. Solutions
14.4.1.1.2.1. Central
patient monitoring systems
14.4.1.1.2.2. Mobile
patent monitoring solutions
14.4.1.1.2.3. Others
14.4.1.1.3. IT Infrastructure
14.4.1.1.4. Services
14.4.1.1.5. Others
14.4.1.2. Brazil
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Application
14.4.1.2.1. Elderly
14.4.1.2.2. Disabled
14.4.1.2.3. Chronically ill patients
14.4.1.2.4. Others
14.4.2. Argentina
14.4.2.1. Argentina
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Offering
14.4.2.1.1. Devices
14.4.2.1.1.1. Wearable
heart monitors
14.4.2.1.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
14.4.2.1.1.3. Home
IV Pumps and Mobility solutions
14.4.2.1.1.4. Apnea
and Sleep Monitors
14.4.2.1.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
14.4.2.1.1.6. Medication
monitoring and Pulse Oximeter
14.4.2.1.1.7. Blood
pressure monitor and Glucose monitors
14.4.2.1.1.8. Skin
patches, shoes and belts
14.4.2.1.1.9. Maternity
care trackers
14.4.2.1.1.10. Others
14.4.2.1.2. Solutions
14.4.2.1.2.1. Central
patient monitoring systems
14.4.2.1.2.2. Mobile
patent monitoring solutions
14.4.2.1.2.3. Others
14.4.2.1.3. IT Infrastructure
14.4.2.1.4. Services
14.4.2.1.5. Others
14.4.2.2. Argentina
Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Application
14.4.2.2.1. Elderly
14.4.2.2.2. Disabled
14.4.2.2.3. Chronically ill patients
14.4.2.2.4. Others
14.4.3. Rest of
Latin America
14.4.3.1. Rest
of Latin America Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn)
and Forecasts, By Offering
14.4.3.1.1. Devices
14.4.3.1.1.1. Wearable
heart monitors
14.4.3.1.1.2. Home
Respiratory Therapy Equipment and Insulin Delivery Devices
14.4.3.1.1.3. Home
IV Pumps and Mobility solutions
14.4.3.1.1.4. Apnea
and Sleep Monitors
14.4.3.1.1.5. Anticoagulation
testing device and Electrocardiography (ECG) devices
14.4.3.1.1.6. Medication
monitoring and Pulse Oximeter
14.4.3.1.1.7. Blood
pressure monitor and Glucose monitors
14.4.3.1.1.8. Skin
patches, shoes and belts
14.4.3.1.1.9. Maternity
care trackers
14.4.3.1.1.10. Others
14.4.3.1.2. Solutions
14.4.3.1.2.1. Central
patient monitoring systems
14.4.3.1.2.2. Mobile
patent monitoring solutions
14.4.3.1.2.3. Others
14.4.3.1.3. IT Infrastructure
14.4.3.1.4. Services
14.4.3.1.5. Others
14.4.3.2. Rest
of Latin America Home-Care Monitoring and Diagnostics Market Revenue (US$ Mn)
and Forecasts, By Application
14.4.3.2.1. Elderly
14.4.3.2.2. Disabled
14.4.3.2.3. Chronically ill patients
14.4.3.2.4. Others
14.5. Key
Segment for Channeling Investments
14.5.1. By
Country
14.5.2. By
Offering
14.5.3. By
Application
15. Competitive Benchmarking
15.1. Brand
Benchmarking
15.2. Market
Share Analysis, 2021
15.3. Global
Presence and Growth Strategies
15.3.1. Mergers
and Acquisitions
15.3.2. Product
Launches
15.3.3. Investments
Trends
15.3.4. R&D
Initiatives
16. Player Profiles
16.1. Abbott
Diagnostics
16.1.1. Company
Details
16.1.2. Company
Overview
16.1.3. Product
Offerings
16.1.4. Key
Developments
16.1.5. Financial
Analysis
16.1.6. SWOT
Analysis
16.1.7. Business
Strategies
16.2. Althea Group
16.2.1. Company
Details
16.2.2. Company
Overview
16.2.3. Product
Offerings
16.2.4. Key
Developments
16.2.5. Financial
Analysis
16.2.6. SWOT
Analysis
16.2.7. Business
Strategies
16.3. Bioptik Technology
16.3.1. Company
Details
16.3.2. Company
Overview
16.3.3. Product
Offerings
16.3.4. Key
Developments
16.3.5. Financial
Analysis
16.3.6. SWOT
Analysis
16.3.7. Business
Strategies
16.4. Chongqing Haray International Business
16.4.1. Company
Details
16.4.2. Company
Overview
16.4.3. Product
Offerings
16.4.4. Key
Developments
16.4.5. Financial
Analysis
16.4.6. SWOT
Analysis
16.4.7. Business
Strategies
16.5. Comarch SA.
16.5.1. Company
Details
16.5.2. Company
Overview
16.5.3. Product
Offerings
16.5.4. Key
Developments
16.5.5. Financial
Analysis
16.5.6. SWOT
Analysis
16.5.7. Business
Strategies
16.6. General Electric Company
16.6.1. Company
Details
16.6.2. Company
Overview
16.6.3. Product
Offerings
16.6.4. Key
Developments
16.6.5. Financial
Analysis
16.6.6. SWOT
Analysis
16.6.7. Business
Strategies
16.7. Johnson & Johnson
16.7.1. Company
Details
16.7.2. Company
Overview
16.7.3. Product
Offerings
16.7.4. Key Developments
16.7.5. Financial
Analysis
16.7.6. SWOT
Analysis
16.7.7. Business
Strategies
16.8. Koninklijke Philips N.V.
16.8.1. Company
Details
16.8.2. Company
Overview
16.8.3. Product
Offerings
16.8.4. Key
Developments
16.8.5. Financial
Analysis
16.8.6. SWOT
Analysis
16.8.7. Business
Strategies
16.9. Medtronic
16.9.1. Company
Details
16.9.2. Company
Overview
16.9.3. Product
Offerings
16.9.4. Key
Developments
16.9.5. Financial
Analysis
16.9.6. SWOT
Analysis
16.9.7. Business
Strategies
16.10. Omron Healthcare
16.10.1. Company
Details
16.10.2. Company
Overview
16.10.3. Product
Offerings
16.10.4. Key
Developments
16.10.5. Financial
Analysis
16.10.6. SWOT
Analysis
16.10.7. Business
Strategies
16.11. Roche Diagnostics
16.11.1. Company
Details
16.11.2. Company
Overview
16.11.3. Product
Offerings
16.11.4. Key
Developments
16.11.5. Financial
Analysis
16.11.6. SWOT
Analysis
16.11.7. Business
Strategies
Other
Market Participants
17. Key Findings
Note: This
ToC is tentative and can be changed according to the research study conducted
during the course of report completion.
**Exclusive for Multi-User and
Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
